Icecure Historical Financial Ratios
| ICCM Stock | USD 0.83 0.04 5.06% |
Icecure Medical is lately reporting on over 86 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 4.22 or Days Sales Outstanding of 12.24 will help investors to properly organize and evaluate Icecure Medical financial condition quickly.
Icecure |
About Icecure Financial Ratios Analysis
Icecure MedicalFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Icecure Medical investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Icecure financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Icecure Medical history.
Icecure Medical Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Icecure Medical stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Icecure Medical sales, a figure that is much harder to manipulate than other Icecure Medical multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Capex To Depreciation
The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Capex To Revenue
The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.Most ratios from Icecure Medical's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Icecure Medical current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Icecure Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.At this time, Icecure Medical's Days Payables Outstanding is very stable compared to the past year. As of the 29th of November 2024, Net Debt To EBITDA is likely to grow to 0.86, while Book Value Per Share is likely to drop 0.25.
| 2022 | 2023 | 2024 (projected) | Payables Turnover | 2.3 | 3.84 | 3.52 | Days Of Inventory On Hand | 635.86 | 430.47 | 259.86 |
Icecure Medical fundamentals Correlations
Click cells to compare fundamentals
Icecure Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Icecure Medical fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 309.01 | 146.77 | 21.04 | 18.6 | 15.12 | 14.37 | |
| Ptb Ratio | 195.04 | 130.81 | 3.23 | 2.26 | 4.01 | 4.22 | |
| Book Value Per Share | 0.29 | 0.19 | 0.27 | 0.94 | 0.69 | 0.25 | |
| Free Cash Flow Yield | (0.0036) | (0.006599) | (0.15) | (0.26) | (0.27) | (0.25) | |
| Operating Cash Flow Per Share | (0.13) | (0.22) | (0.44) | (0.39) | (0.27) | (0.29) | |
| Stock Based Compensation To Revenue | 0.22 | 0.0561 | 0.0764 | 0.6 | 0.41 | 0.31 | |
| Capex To Depreciation | 0.66 | 0.89 | 4.2 | 3.59 | 1.49 | 1.06 | |
| Pb Ratio | 195.04 | 130.81 | 3.23 | 2.26 | 4.01 | 4.22 | |
| Ev To Sales | 305.67 | 145.99 | 15.07 | 11.12 | 12.05 | 11.44 | |
| Free Cash Flow Per Share | (0.14) | (0.23) | (0.46) | (0.41) | (0.28) | (0.3) | |
| Roic | (1.75) | (0.97) | (0.37) | (0.67) | (1.28) | (1.34) | |
| Net Income Per Share | (0.3) | (0.35) | (0.28) | (0.47) | (0.32) | (0.34) | |
| Days Of Inventory On Hand | 242.16 | 292.33 | 367.25 | 635.86 | 430.47 | 259.86 | |
| Payables Turnover | 1.38 | 2.54 | 2.21 | 2.3 | 3.84 | 3.52 | |
| Sales General And Administrative To Revenue | 0.79 | 0.43 | 1.0 | 1.9 | 1.29 | 1.56 | |
| Average Inventory | 309.9K | 476.8K | 929.8K | 1.5M | 1.4M | 1.5M | |
| Research And Ddevelopement To Revenue | 1.72 | 1.0 | 1.42 | 2.96 | 2.56 | 1.52 | |
| Capex To Revenue | 0.0617 | 0.0582 | 0.13 | 0.29 | 0.15 | 0.0784 | |
| Cash Per Share | 0.36 | 0.42 | 0.48 | 0.9 | 0.64 | 0.24 | |
| Pocfratio | (294.05) | (161.25) | (6.91) | (4.01) | (3.9) | (4.1) | |
| Interest Coverage | (49.96) | (202.02) | (137.5) | (70.04) | (80.54) | (84.57) | |
| Capex To Operating Cash Flow | (0.0587) | (0.064) | (0.0423) | (0.0623) | (0.0383) | (0.0403) | |
| Pfcf Ratio | (277.75) | (151.55) | (6.63) | (3.78) | (3.76) | (3.94) | |
| Days Payables Outstanding | 143.7 | 165.07 | 165.5 | 158.91 | 94.99 | 107.86 | |
| Income Quality | 0.36 | 0.79 | 1.27 | 0.84 | 0.85 | 0.67 | |
| Roe | (1.81) | (1.04) | (0.37) | (0.68) | (1.2) | (1.14) | |
| Ev To Operating Cash Flow | (290.87) | (160.38) | (4.95) | (2.4) | (3.11) | (3.26) | |
| Pe Ratio | (134.34) | (107.6) | (125.49) | (8.65) | (3.33) | (3.5) | |
| Return On Tangible Assets | (0.65) | (0.46) | (0.31) | (0.57) | (0.89) | (0.94) | |
| Ev To Free Cash Flow | (274.75) | (150.74) | (4.75) | (2.26) | (2.99) | (3.14) | |
| Earnings Yield | (0.007444) | (0.009294) | (0.007969) | (0.12) | (0.3) | (0.29) | |
| Net Debt To E B I T D A | 1.23 | 1.2 | 0.78 | 2.57 | 1.4 | 0.86 | |
| Current Ratio | 1.9 | 2.48 | 7.54 | 6.49 | 3.66 | 4.95 | |
| Tangible Book Value Per Share | 0.29 | 0.19 | 0.27 | 0.94 | 0.69 | 0.25 | |
| Graham Number | 1.23 | 1.3 | 2.74 | 2.68 | 1.39 | 1.32 | |
| Shareholders Equity Per Share | 0.29 | 0.19 | 0.27 | 0.94 | 0.69 | 0.25 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Icecure Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icecure Medical. If investors know Icecure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icecure Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.28) | Revenue Per Share 0.071 | Quarterly Revenue Growth 0.079 | Return On Assets (0.47) | Return On Equity (0.94) |
The market value of Icecure Medical is measured differently than its book value, which is the value of Icecure that is recorded on the company's balance sheet. Investors also form their own opinion of Icecure Medical's value that differs from its market value or its book value, called intrinsic value, which is Icecure Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icecure Medical's market value can be influenced by many factors that don't directly affect Icecure Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icecure Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icecure Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icecure Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.